Literature DB >> 16880646

Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.

Tsutomu Harada1, Ryuichi Narazaki, Shinsuke Nagira, Takayuki Ohwaki, Shigeru Aoki, Kiyoshi Iwamoto.   

Abstract

The purpose of this study was to demonstrate the usefulness and broad-applicability of a simple disintegration test method for orally disintegrating tablets (ODT). Eight types of commercial famotidine 20 mg orally disintegrating tablets with different physical properties (formulation, manufacturing method, tablet weight, shape, diameter, thickness, etc.), were used. Disintegration times of these tablets were evaluated employing human sensory test, conventional disintegration test, and the new proposed disintegration test. The human sensory test was performed in 5 healthy volunteers. In the conventional disintegration test, the disintegration apparatus described in the Japanese Pharmacopeia (JP 1(st)) was used. Our proposed new test which is characterized by a rotating shaft with a low weight (10, 15 g) and rotation speed (10, 25, 50 rpm) was evaluated using tablets with and without storage under severe conditions (60 degrees C/75%RH for 1 week). The disintegration times of famotidine 20 mg orally disintegrating tablets in human sensory test varied from 9 to 32 s. In contrast, disintegration times in the conventional test were prolonged to over 300 s. Disintegration times in the new proposed test were close to those in human sensory test. Especially, when the new test was conducted with 15 or 10 g weight and 25 rpm, the slope (human sensory test vs. new proposed test) was almost 1. We were able to demonstrate that the new proposed test was useful to estimate the actual human disintegration time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880646     DOI: 10.1248/cpb.54.1072

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  Functionalized calcium carbonate as a novel pharmaceutical excipient for the preparation of orally dispersible tablets.

Authors:  Tanja Stirnimann; Nicola Di Maiuta; Daniel E Gerard; Rainer Alles; Jörg Huwyler; Maxim Puchkov
Journal:  Pharm Res       Date:  2013-04-19       Impact factor: 4.200

2.  Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.

Authors:  Jasdip S Koner; Ali R Rajabi-Siahboomi; Shahrzad Missaghi; Daniel Kirby; Yvonne Perrie; Jiteen Ahmed; Afzal R Mohammed
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

Review 3.  Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.

Authors:  Mohammadali Poursharifi Ghourichay; Seyed Hossein Kiaie; Ali Nokhodchi; Yousef Javadzadeh
Journal:  Biomed Res Int       Date:  2021-12-24       Impact factor: 3.411

4.  Formulation, optimization and evaluation of levocetirizine dihyrochloride oral thin strip.

Authors:  J Gunjan Patel; A Darshan Modi
Journal:  J Pharm Bioallied Sci       Date:  2012-03

5.  The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs).

Authors:  Witold Brniak; Renata Jachowicz; Przemyslaw Pelka
Journal:  Saudi Pharm J       Date:  2015-01-16       Impact factor: 4.330

6.  Mimicking the Impact of Infant Tongue Peristalsis on Behavior of Solid Oral Dosage Forms Administered During Breastfeeding.

Authors:  Rebekah L Scheuerle; Richard A Kendall; Catherine Tuleu; Nigel K H Slater; Stephen E Gerrard
Journal:  J Pharm Sci       Date:  2016-09-26       Impact factor: 3.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.